Ladenheim EE
Autoimmune patients planning to stop tirzepatide should taper gradually rather than stopping abruptly, and should have their autoimmune specialist monitor disease activity closely during and after the transition
Therefore, lifestyle and pharmacological options must be evaluated to improve or prevent those obesity underlying pathologies
Unimolecular peptides with dual GIP/GLP-1 receptor agonism have been developed to improve metabolic efficacy and therapeutic index beyond what incretin mono-agonists can achieve (44, 63)
They can also be used along with other diabetes medications, like metformin, if needed
[Umbelliferae, Bupleuri Radix] are mainly flavonoids, such as saikosaponin, saikgenin, quercetin, etc., and contain saikosaponin, polysaccharide, volatile oil, etc